Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
GLOB-1: a prospective randomised clinical phase III trial comparing vinorelbine-cisplatin with vinorelbine-ifosfamide-cisplatin in metastatic non-small-cell lung cancer patients.
Souquet PJ, Tan EH, Rodrigues Pereira J, Van Klaveren R, Price A, Gatzemeier U, Jaworski M, Burillon JP, Aubert D. Souquet PJ, et al. Among authors: burillon jp. Ann Oncol. 2002 Dec;13(12):1853-61. doi: 10.1093/annonc/mdf316. Ann Oncol. 2002. PMID: 12453852 Free article. Clinical Trial.
Randomized study of vinorelbine--gemcitabine versus vinorelbine--carboplatin in patients with advanced non-small cell lung cancer.
Tan EH, Szczesna A, Krzakowski M, Macha HN, Gatzemeier U, Mattson K, Wernli M, Reiterer P, Hui R, Pawel JV, Bertetto O, Pouget JC, Burillon JP, Parlier Y, Abratt R; GLOB 2 group. Tan EH, et al. Among authors: burillon jp. Lung Cancer. 2005 Aug;49(2):233-40. doi: 10.1016/j.lungcan.2005.03.029. Lung Cancer. 2005. PMID: 16022917 Clinical Trial.
A randomised, multicentre open-label phase II study to evaluate the efficacy, tolerability and pharmacokinetics of oral vinorelbine plus cisplatin versus intravenous vinorelbine plus cisplatin in Chinese patients with chemotherapy-naive unresectable or metastatic non-small cell lung cancer.
Yang Y, Chang J, Huang C, Zhang Y, Wang J, Shu Y, Burillon JP, Riggi M, Petain A, Ferre P, Liang Y, Zhang L. Yang Y, et al. Among authors: burillon jp. J Thorac Dis. 2019 Aug;11(8):3347-3359. doi: 10.21037/jtd.2019.08.22. J Thorac Dis. 2019. PMID: 31559038 Free PMC article.